RE: Rns incoming20 Aug 2024 04:14
Hereforhemo - you may be very close with your numbers, although remember that’s potential revenue. Profit would be nearer half of that after costs, so approx 5p per share. That to me is a realistic target.
I think we should also consider that HE1 may sell just this asset, and continue exploring - payout to shareholders via a special dividend may then only be a proportion of this (retaining the remainder for future drills etc).
So for me, suggested valuations over 15pps are highly ambitious.
Good luck all, and I can’t wait for news by next week.